Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Chemical Communications (Cambridge, England)|November 4, 2009
A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activityDarren Griffith, Maria P Morgan, Celine J Marmion
Anti-Cancer Agents in Medicinal Chemistry|April 13, 2010
Enzyme inhibition as a key target for the development of novel metal-based anti-cancer therapeuticsDarren Griffith, James P Parker, Celine J Marmion
BMC Medical Education|November 19, 2025
Approaches to learning in pre-medicine: a multi-university mixed-methods studyDeclan Gaynor, Fiza Rashid-Doubell, Celine J Marmion, et al.
Dalton Transactions (Cambridge, England : 2003)|December 4, 2008
The reduction of platinum(IV) and palladium(IV) ions by 2,6-pyridinedihydroxamic acidDarren Griffith, Atish Chopra, Helge Müller-Bunz, et al.
Current Topics in Medicinal Chemistry|December 8, 2004
Ruthenium as an effective nitric oxide scavengerCeline J Marmion, Beth Cameron, Clodagh Mulcahy, et al.
Journal of Inorganic Biochemistry|February 24, 2020
Vorinostat and Belinostat, hydroxamate-based anti-cancer agents, are nitric oxide donorsReece G Kenny, Ziga Ude, James R Docherty, et al.
Molecular Pharmaceutics|September 8, 2018
Innovative DNA-Targeted Metallo-prodrug Strategy Combining Histone Deacetylase Inhibition with Oxidative StressTadhg J P McGivern, Creina Slator, Andrew Kellett, et al.
Dalton Transactions (Cambridge, England : 2003)|February 24, 2005
Novel platinum(II) ammine hydroxamate and hydroximate complexes and the platinum-assisted hydrolysis of hydroxamic acidsDarren Griffith, Konstantin Lyssenko, Paul Jensen, et al.
Pageof 3